Beijing Tiantan Biological Products Corp Ltd (600161) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally.

Total Assets Chart for Beijing Tiantan Biological Products Corp Ltd

Beijing Tiantan Biological Products Corp Ltd (600161) total assets for FY2025 were CNY 16.6B, a 4.8% change from FY2024. Beijing Tiantan Biological Products Corp Ltd's total assets grew from CNY 124.8M in 1995 to CNY 16.6B in 2025 (13224.5% over 30 years). Total assets compound annual growth rate: 5-year CAGR of 17.1%, 10-year CAGR of 11.4%, 20-year CAGR of 16.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥24.28B
Implied Share Price
¥12.28
Enterprise Value
¥22.09B
Revenue (TTM)
¥5.65B
EBITDA
¥1.68B
Profit Margin
13.39%
Trailing P/E
32.32
Forward P/E
17.67
Price/Book (MRQ)
2.02
Price/Sales (TTM)
4.30
EV/EBITDA
12.60
EV/Revenue
3.91
Dividend Yield
1.64%
Book Value
¥6.33
Free Cash Flow (FY2025)
-¥229.59M
Free Cash Flow Yield
-0.95%

Snapshot as of 5th September 2026 — not point-in-time controlled, may lag the live market by a few days.